Percutaneous interstitial fluid glucose monitoring system, electrochemical. An assembly of electrically-powered, portable devices intended to continuously monitor interstitial fluid glucose concentrations in a patient with diabetes mellitus, using an invasive electrochemical technique. It consists of an electrochemical, percutaneously-inserted electrode that physically connects to a cable or transmitter which communicates with a monitor or receiver (not included) that captures, stores, and converts the sensor signals to glucose concentrations for display. The system may be used in the home and clinical settings, and aids in the detection of episodes of hyperglycaemia and hypoglycaemia, facilitating acute/long-term therapy adjustments.
Integrated continuous glucose monitoring system, factory calibrated, not for use with automated insulin delivery systems. An integrated continuous glucose monitoring system for replacement of finger stick blood glucose testing for diabetes treatment decisions in persons with diabetes, unless otherwise indicated. The system automatically measures glucose in bodily fluids continuously or frequently for a specified period of time. The system is also designed to reliably and securely transmit glucose measurement data to digitally connected devices and are intended to be used alone or in conjunction with these digitally connected devices where the user manually controls actions for therapy decisions. The system is not intended to be used with automated insulin dosing (AID) systems.
Only your prescriber can say whether a device is right for you.
In the FDA’s device database
Needs a prescription.
Its labeling says “MR Unsafe”: it can’t go into an MRI machine. Tell the MRI staff you use it.
Company on its FDA records: Abbott Diabetes Care. Its support line: +1(855)632-8658.
6 versions sold now
Each opens its FDA record. The model number is on the box.